Sarepta Therapeutics (SRPT) Other Accumulated Expenses (2010 - 2026)
Sarepta Therapeutics' quarterly Other Accumulated Expenses came in at $10.4 million in Q1 2026, up 3.6% year-on-year from $10.0 million in Q1 2025, and up 49.02% quarter-over-quarter from $7.0 million in Q4 2025.
Sarepta Therapeutics has reported Other Accumulated Expenses for 17 years, with the latest figure at $10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 3.6% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (up 3.6% YoY), and the FY2025 full-year result was $7.0 million, down 48.3% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $10.4 million, up from $7.0 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $26.2 million in Q3 2022, with the low at $4.4 million in Q1 2023.
- Average Other Accumulated Expenses over 5 years is $10.5 million, with a median of $9.8 million recorded in 2023.
- Year-over-year, Other Accumulated Expenses slumped 75.5% in 2023 and jumped 123.81% in 2024.
- Tracing SRPT's Other Accumulated Expenses over 5 years: stood at $5.3 million in 2022, then gained by 21.81% to $6.5 million in 2023, then surged by 108.14% to $13.5 million in 2024, then sank by 48.3% to $7.0 million in 2025, then soared by 49.02% to $10.4 million in 2026.
- The last three Other Accumulated Expenses figures came in at $10.4 million (Q1 2026), $7.0 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.38 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 5.93 Mn |
| Mar 31, 2025 | 10.02 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 17.29 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 6.47 Mn |
| Sep 30, 2023 | 7.73 Mn |
| Jun 30, 2023 | 9.79 Mn |
| Mar 31, 2023 | 4.36 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 26.21 Mn |
| Jun 30, 2022 | 16.42 Mn |
| Mar 31, 2022 | 17.80 Mn |
| Dec 31, 2021 | 15.05 Mn |
| Sep 30, 2021 | 19.03 Mn |
| Jun 30, 2021 | 18.96 Mn |
| Mar 31, 2021 | 18.21 Mn |
| Dec 31, 2020 | 22.14 Mn |
| Sep 30, 2020 | 15.55 Mn |
| Jun 30, 2020 | 14.84 Mn |
| Mar 31, 2020 | 12.46 Mn |
| Dec 31, 2019 | 7.84 Mn |
| Sep 30, 2019 | 2.64 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 6.76 Mn |
| Dec 31, 2018 | 5.77 Mn |
| Sep 30, 2018 | 444,000.00 |
| Jun 30, 2018 | 1.41 Mn |
| Mar 31, 2018 | 2.86 Mn |
| Dec 31, 2017 | 2.48 Mn |
| Sep 30, 2017 | 2.92 Mn |
| Jun 30, 2017 | 1.34 Mn |
| Mar 31, 2017 | 1.38 Mn |
| Dec 31, 2016 | 1.31 Mn |
| Sep 30, 2016 | 1.17 Mn |
| Jun 30, 2016 | 2.55 Mn |
| Mar 31, 2016 | 722,000.00 |
| Dec 31, 2015 | 1.56 Mn |
| Sep 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 735,000.00 |
| Mar 31, 2015 | 1.26 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Sep 30, 2014 | 784,000.00 |
| Jun 30, 2014 | 730,000.00 |
| Mar 31, 2014 | 800,000.00 |
| Dec 31, 2013 | 1.28 Mn |
| Sep 30, 2013 | 15,000.00 |
| Jun 30, 2013 | 15,000.00 |
| Mar 31, 2013 | 15,000.00 |
| Dec 31, 2012 | 27,000.00 |
| Mar 31, 2012 | 114,000.00 |
| Dec 31, 2011 | 126,000.00 |
| Sep 30, 2011 | 105,000.00 |
| Jun 30, 2011 | 85,000.00 |
| Dec 31, 2010 | 35,000.00 |